한국어
English
日本語
中文(简体)
Vesicaren 5.33 mg (Solifenacin Tartaric Acid)
5.33mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Solifenacin tartrate is an active ingredient that alleviates symptoms of overactive bladder.
MFDS ingredient code M264981
Solifenacin tartrate is an antimuscarinic agent that acts on the smooth muscle of the bladder. It is primarily used to relieve symptoms of frequent urination, urgency, and urinary incontinence caused by overactive bladder.
This ingredient works by blocking muscarinic receptors in the bladder muscle, inhibiting excessive contractions of the bladder. As a result, the bladder becomes more stable, and the ability to hold urine improves.
Approved uses differ by product. Check each product's information for its actual use.
Compared to other antimuscarinic agents, solifenacin tartrate selectively acts on the bladder, resulting in relatively fewer side effects. It also has a characteristic of maintaining its effectiveness even with long-term use.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
